Your browser doesn't support javascript.
loading
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.
Wu, Lirong; Zhu, Jun; Rudqvist, Nils-Petter; Welsh, James; Lee, Percy; Liao, Zhongxing; Xu, Ting; Jiang, Ming; Zhu, Xiangzhi; Pan, Xuan; Li, Pansong; Zhou, Zhipeng; He, Xia; Yin, Rong; Feng, Jifeng.
Afiliação
  • Wu L; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Zhu J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Rudqvist NP; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Welsh J; Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Lee P; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Liao Z; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Xu T; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Jiang M; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Zhu X; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Pan X; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Li P; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Zhou Z; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • He X; Department of Scientific Research, Geneplus-Beijing Institute, Beijing, China.
  • Yin R; Department of Scientific Research, Geneplus-Beijing Institute, Beijing, China.
  • Feng J; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Front Immunol ; 12: 719285, 2021.
Article em En | MEDLINE | ID: mdl-34733273
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça